Dr. Rushim Bains, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 21481 N Rand Rd, Kildeer, IL 60047 Phone: 847-618-9696 Fax: 847-618-9695 |
Dr. Evelyn Strzyz White, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 21481 N Rand Rd, Kildeer, IL 60047 Phone: 847-618-9696 Fax: 847-618-9695 |
Heidi Wehlus, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 21481 N Rand Rd, Kildeer, IL 60047 Phone: 847-618-9696 Fax: 847-618-9695 |
News Archive
Florida-based biopharmaceutical leader Oragenics, Inc. has appointed renowned international oral care authority Dr. Raman Bedi to serve as exclusive representative for the company's award-winning line of oral care products to the Middle East.
A new study indicates that red meat intake may increase the risk of kidney failure in the general population, and substituting red meat with alternative sources of protein from time to time may significantly reduce this risk.
The dramatic expansion of health care coverage that received final approval in Congress on Sunday means that controlling medical costs will be more important than ever. As The Concord Coalition has repeatedly pointed out, expanding coverage without curbing costs is a recipe for fiscal disaster.
In the latest scare over hormone replacement therapy (HRT) it is thought a thousand British women may have died from ovarian cancer since 1991 because they were using the therapy.
Takeda Pharmaceutical Company Limited and its wholly-owned subsidiary, Takeda Pharmaceuticals International GmbH, today announced that the European Commission has granted Marketing Authorisation for Entyvio (vedolizumab), a gut-selective humanized monoclonal antibody, and the first and only biologic therapy to be approved simultaneously for the treatment of adults with moderately to severely active ulcerative colitis (UC) and adults with moderately to severely active Crohn's disease (CD) who have had an inadequate response with, lost response to, or were intolerant to either conventional therapy or a tumor necrosis factor-alpha (TNFα) antagonist.
› Verified 7 days ago